Temperature‐corrected proton density fat fraction estimation using chemical shift‐encoded MRI in phantoms
- 9 February 2021
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 86 (1), 69-81
- https://doi.org/10.1002/mrm.28669
Abstract
Purpose Chemical shift‐encoded MRI (CSE‐MRI) is well‐established to quantify proton density fat fraction (PDFF) as a quantitative biomarker of hepatic steatosis. However, temperature is known to bias PDFF estimation in phantom studies. In this study, strategies were developed and evaluated to correct for the effects of temperature on PDFF estimation through simulations, temperature‐controlled experiments, and a multi‐center, multi‐vendor phantom study. Theory and Methods A technical solution that assumes and automatically estimates a uniform, global temperature throughout the phantom is proposed. Computer simulations modeled the effect of temperature on PDFF estimation using magnitude‐, complex‐, and hybrid‐based CSE‐MRI methods. Phantom experiments were performed to assess the temperature correction on PDFF estimation at controlled phantom temperatures. To assess the temperature correction method on a larger scale, the proposed method was applied to data acquired as part of a nine‐site multi‐vendor phantom study and compared to temperature‐corrected PDFF estimation using an a priori guess for ambient room temperature. Results Simulations and temperature‐controlled experiments show that as temperature deviates further from the assumed temperature, PDFF bias increases. Using the proposed correction method and a reasonable a priori guess for ambient temperature, PDFF bias and variability were reduced using magnitude‐based CSE‐MRI, across MRI systems, field strengths, protocols, and varying phantom temperature. Complex and hybrid methods showed little PDFF bias and variability both before and after correction. Conclusion Correction for temperature reduces temperature‐related PDFF bias and variability in phantoms across MRI vendors, sites, field strengths, and protocols for magnitude‐based CSE‐MRI, even without a priori information about the temperature.Funding Information
- National Institutes of Health (K24 DK102595, R01 DK088925, R01 DK100651, R01 DK117354, R41 EB025729, R44 EB025729)
This publication has 31 references indexed in Scilit:
- Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-AnalysisRadiology, 2018
- Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver diseaseJournal of Hepatology, 2017
- Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic SteatohepatitisGastroenterology, 2017
- Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver diseaseScandinavian Journal of Gastroenterology, 2014
- Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adultsAlimentary Pharmacology & Therapeutics, 2011
- Combination of complex‐based and magnitude‐based multiecho water‐fat separation for accurate quantification of fat‐fractionMagnetic Resonance in Medicine, 2011
- Liver biopsyJournal of Hepatology, 2008
- Multiecho water‐fat separation and simultaneous R estimation with multifrequency fat spectrum modelingMagnetic Resonance in Medicine, 2008
- Relaxation effects in the quantification of fat using gradient echo imagingMagnetic Resonance Imaging, 2008
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severityGastroenterology, 1999